SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-005105
Filing Date
2017-05-12
Accepted
2017-05-12 12:30:29
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 658240
2 ex31-1.htm EX-31.1 22448
3 ex32-1.htm EX-32.1 9076
  Complete submission text file 0001493152-17-005105.txt   3227550

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE imun-20170331.xml EX-101.INS 518905
5 XBRL SCHEMA FILE imun-20170331.xsd EX-101.SCH 48406
6 XBRL CALCULATION FILE imun-20170331_cal.xml EX-101.CAL 42023
7 XBRL DEFINITION FILE imun-20170331_def.xml EX-101.DEF 132673
8 XBRL LABEL FILE imun-20170331_lab.xml EX-101.LAB 283968
9 XBRL PRESENTATION FILE imun-20170331_pre.xml EX-101.PRE 204183
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 17837426
SIC: 2834 Pharmaceutical Preparations